{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:54:00Z","timestamp":1761544440516,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.japh.2021.12.006","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:29:57Z","timestamp":1639826997000},"page":"864-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quality improvement to evaluate and provide treatment for chronic hepatitis C postpartum"],"prefix":"10.1016","volume":"62","author":[{"given":"Casey","family":"Behnke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8084-5561","authenticated-orcid":false,"given":"Oriel","family":"Nissim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3807-5342","authenticated-orcid":false,"given":"Whitney","family":"Simerlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-1863","authenticated-orcid":false,"given":"Kristin","family":"Beeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Tarleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5233-442X","authenticated-orcid":false,"given":"Gweneth B.","family":"Lazenby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.japh.2021.12.006_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.15585\/mmwr.mm6618a3","article-title":"Hepatitis C virus infection among women giving birth - Tennessee and United States, 2009-2014","volume":"66","author":"Patrick","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"S 01","key":"10.1016\/j.japh.2021.12.006_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0040-1709672","article-title":"Hepatitis C virus in pregnancy: a systematic review of the literature","volume":"38","author":"Andes","year":"2021","journal-title":"Am J Perinatol"},{"issue":"2","key":"10.1016\/j.japh.2021.12.006_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0000000000003644","article-title":"Reported prevalence of maternal hepatitis C virus infection in the United States","volume":"135","author":"Rossi","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.japh.2021.12.006_bib4","doi-asserted-by":"crossref","first-page":"e20173273","DOI":"10.1542\/peds.2017-3273","article-title":"Hepatitis C virus screening among children exposed during pregnancy","volume":"141","author":"Chappell","year":"2018","journal-title":"Pediatrics"},{"issue":"2 Pt 1","key":"10.1016\/j.japh.2021.12.006_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/AOG.0b013e318180a4f3","article-title":"Chronic hepatitis C in pregnancy","volume":"112","author":"Berkley","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.japh.2021.12.006_bib6","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/14767058.2013.829813","article-title":"Obstetric management does not influence vertical transmission of HCV infection: results of the ALHICE group study","volume":"27","author":"Delotte","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"12","key":"10.1016\/j.japh.2021.12.006_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/jp.2014.167","article-title":"Hepatitis B and C in pregnancy: a review and recommendations for care","volume":"34","author":"Dunkelberg","year":"2014","journal-title":"J\u00a0Perinatol"},{"issue":"6","key":"10.1016\/j.japh.2021.12.006_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/cid\/ciu447","article-title":"Vertical transmission of hepatitis C virus: systematic review and meta-analysis","volume":"59","author":"Benova","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.japh.2021.12.006_bib9","doi-asserted-by":"crossref","unstructured":"Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Treatment and prevention of viral hepatitis in pregnancy [e-pub ahead of print]. Am J Obstet Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2021.09.002. accessed December 14, 2021.","DOI":"10.1016\/j.ajog.2021.09.002"},{"issue":"8","key":"10.1016\/j.japh.2021.12.006_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/cid\/ciw026","article-title":"Failure to test and identify perinatally infected children born to hepatitis C virus-infected women","volume":"62","author":"Kuncio","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2021.12.006_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.14423\/SMJ.0000000000000988","article-title":"Increasing prevalence of chronic hepatitis C virus infection in a southern academic obstetrical clinic","volume":"112","author":"Lazenby","year":"2019","journal-title":"South Med J"},{"issue":"8","key":"10.1016\/j.japh.2021.12.006_bib12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1007\/s10995-018-2506-1","article-title":"Hepatitis C virus knowledge among pregnant women with opioid use disorder","volume":"22","author":"Krans","year":"2018","journal-title":"Matern Child Health J"},{"issue":"2","key":"10.1016\/j.japh.2021.12.006_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults - United States, 2020","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"10","key":"10.1016\/j.japh.2021.12.006_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jama.2020.1123","article-title":"Screening for hepatitis C virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement","volume":"323","author":"Owens","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.japh.2021.12.006_bib16","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/NPM-15915024","article-title":"Hepatitis C virus universal screening versus risk based selective screening during pregnancy","volume":"8","author":"Waruingi","year":"2015","journal-title":"J\u00a0Neonatal Perinatal Med"},{"issue":"2","key":"10.1016\/j.japh.2021.12.006_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11901-019-00468-y","article-title":"Testing for hepatitis C in pregnancy: the time has come for routine rather than risk-based","volume":"18","author":"Kushner","year":"2019","journal-title":"Curr Hepatol Rep"},{"issue":"3","key":"10.1016\/j.japh.2021.12.006_bib18","doi-asserted-by":"crossref","first-page":"ofy043","DOI":"10.1093\/ofid\/ofy043","article-title":"Risk-based hepatitis C screening in pregnancy is less reliable than universal screening: a retrospective chart review","volume":"5","author":"Boudova","year":"2018","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.japh.2021.12.006_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/S106474490300005X","article-title":"Screening and counseling practices reported by obstetrician-gynecologists for patients with hepatitis C virus infection","volume":"11","author":"Boaz","year":"2003","journal-title":"Infect Dis Obstet Gynecol"},{"key":"10.1016\/j.japh.2021.12.006_bib20","doi-asserted-by":"crossref","first-page":"8654741","DOI":"10.1155\/2019\/8654741","article-title":"Risk-based prenatal hepatitis C testing practices and results, Alaska 2013-2016","volume":"2019","author":"Nolen","year":"2019","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.japh.2021.12.006_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/AOG.0000000000003062","article-title":"Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care","volume":"133","author":"Tasillo","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.japh.2021.12.006_bib22","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1093\/cid\/ciz063","article-title":"Cost-effectiveness of universal hepatitis C virus screening of pregnant women in the United States","volume":"69","author":"Chaillon","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2021.12.006_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/OGX.0000000000000442","article-title":"Hepatitis C in pregnancy: review of current knowledge and updated recommendations for management","volume":"72","author":"Page","year":"2017","journal-title":"Obstet Gynecol Surv"},{"issue":"7","key":"10.1016\/j.japh.2021.12.006_bib24","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/apt.15476","article-title":"Review article: direct-acting antivirals for the treatment of HCV during pregnancy and lactation - implications for maternal dosing, foetal exposure, and safety for mother and child","volume":"50","author":"Freriksen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.japh.2021.12.006_bib25","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S2666-5247(20)30062-8","article-title":"Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study","volume":"1","author":"Chappell","year":"2020","journal-title":"Lancet Microbe"},{"issue":"4","key":"10.1016\/j.japh.2021.12.006_bib26","first-page":"371","article-title":"Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. European Paediatric hepatitis C virus Network","volume":"108","year":"2001","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.japh.2021.12.006_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0168-8278(00)80075-6","article-title":"Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C","volume":"32","author":"Gervais","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"6","key":"10.1016\/j.japh.2021.12.006_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/cid\/cix445","article-title":"Spontaneous viral load decline and subsequent clearance of chronic hepatitis C virus in postpartum women correlates with favorable Interleukin-28B gene allele","volume":"65","author":"Hashem","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.japh.2021.12.006_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jmv.10471","article-title":"Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection","volume":"71","author":"Hattori","year":"2003","journal-title":"J\u00a0Med Virol"},{"issue":"4","key":"10.1016\/j.japh.2021.12.006_bib30","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.23444","article-title":"Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin","volume":"51","author":"Martinot-Peignoux","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.japh.2021.12.006_bib31","unstructured":"Bagwell A, Chastain C. Improvements following clinical pharmacist integration in the management of hepatitis c. Poster presented to the National Association of Specialty Pharmacy Annual Meeting, Washington, DC. September, 2017. Available at: https:\/\/www.vspoutcomesresearch.com\/outcomes\/projects-by-topic\/#hematology. Last accessed January 5, 2022."},{"issue":"7","key":"10.1016\/j.japh.2021.12.006_bib32","doi-asserted-by":"crossref","first-page":"ofz316","DOI":"10.1093\/ofid\/ofz316","article-title":"Expanding hepatitis C virus care and cure: national experience using a clinical pharmacist-driven model","volume":"6","author":"Koren","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.japh.2021.12.006_bib33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/1060028016683495","article-title":"Evaluation of a hepatitis C patient Management Program at a university specialty pharmacy","volume":"51","author":"Zaepfel","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.japh.2021.12.006_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/jvh.13228","article-title":"Loss to follow-up: a significant barrier in the treatment cascade with direct-acting therapies","volume":"27","author":"Darvishian","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.japh.2021.12.006_bib37","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/hep.31825","article-title":"Responsible inclusion of pregnant individuals in eradicating HCV","volume":"74","author":"Jhaveri","year":"2021","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.japh.2021.12.006_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/hep4.1264","article-title":"Evaluating women's preferences for hepatitis C treatment during pregnancy","volume":"2","author":"Kushner","year":"2018","journal-title":"Hepatol Commun"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121005537?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121005537?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:50:40Z","timestamp":1761544240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121005537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1544319121005537"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.12.006","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality improvement to evaluate and provide treatment for chronic hepatitis C postpartum","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}